euportal twitter euportal facebook

COVID -19 vaccine: Statement by von der Leyen on Moderna

24.11.2020 – “This contract allows us to buy up to 160 million doses of a vaccine produced by Moderna. According to the results of clinical trials, this vaccine could be highly effective against COVID-19. Once the vaccine is indeed proven as safe and effective, every Member State will receive it at the same time, on a pro-rata basis, at the same conditions. With Moderna now, this is the sixth contract we have with a pharmaceutical company for our COVID-19 vaccine portfolio. We are working on yet another one. By this, we are setting up one of the most comprehensive COVID-19 vaccine portfolios in the world. This provides Europeans access to the most promising future vaccines under development so far. Of course, all vaccines from our portfolio will be evaluated very carefully by our European Medicines Agency (EMA). They will only be authorised and placed on the market if they are safe and if they are effective.  Transparency here is crucial and of utmost importance”. More: here


  1. Полина says:

    A vaccine would teach our bodies to fight the infection by stopping us from catching coronavirus, or at least making Covid less deadly. This may be one of the easiest vaccines to distribute, because it does not need to be stored at very cold temperatures.

0 Trackbacks

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>